Malaria Prevention with the Help of Anti-Drug Antibodies

Erich Cerny of Wissenschaftlicher Fonds Onkologie in Switzerland will test whether inducing antibodies against anti-malarial drugs can significantly prolong the half- life of that drug. Antibodies elicited via immunization may form a reservoir of the active drug for long-lasting treatment for malaria. Such a "small molecule vaccine" has significant implications for efficacy and cost of malaria prevention.